about
Fertility Risk Assessment and Preservation in Male and Female Prepubertal and Adolescent Cancer PatientsOxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study.Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.Carboplatin and paclitaxel in metastatic or recurrent cervical cancer.A giant squamous cell carcinoma of the skin of the thoracic wall: a case report and review of the literature.Gastrointestinal Stromal Tumors (GIST): A Prospective Analysis and an Update on Biomarkers and Current Treatment Concepts.Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients.A pleomorphic rhabdomyosarcoma mimicking an inguinal hernia: a case report and review of the literatureThe role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer.Progressive muscle relaxation as a supportive intervention for cancer patients undergoing chemotherapy: A systematic review.Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.A Case of Organizing Pneumonia (OP) Associated with Pembrolizumab.The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients.Advances in assessment and management of carotid body tumors.Hepatoid pancoast tumor. A case report and review of the literature.Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients.Depressive symptoms during adverse economic and political circumstances: A comparative study on Greek female breast cancer patients receiving chemotherapy treatment.Vaccine strategies in the treatment of low-grade non-Hodgkin lymphoma.Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer.Implications of the Incidental Finding of a MYCN Amplified Adrenal Tumor: A Case Report and Update of a Pediatric Disease Diagnosed in Adults.Radiotherapy for Hodgkin's lymphoma: too hard to die?Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.Forming a Stress Management and Health Promotion Program for Women Undergoing Chemotherapy for Breast Cancer: A Pilot Randomized Controlled Trial.Chemotherapy in NETs: When and how.Tumor molecular profiling of NSCLC patients using next generation sequencing.Delivering quality lung cancer care in crisis-wracked Greece.miR-183 as a molecular and protective biomarker for cancer in schizophrenic subjects.Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab.Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients.Pigmented Bowen's diseaseSecond primary renal cell carcinomas following solid tumors. Four case reports and review of the literatureSurvival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decadesLiver metastasis of adenoid cystic carcinoma of salivary origin: report of a case prepared by ThinPrep methodVascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumabBevacizumab plus temozolomide: a novel treatment option for advanced neuroendocrine tumors?Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) StudyTen-year survival outcomes of patients with potentially resectable gastric cancer: impact of clinicopathologic and treatment-related risk factors
P50
Q26743355-C81BCEA8-66C0-4C08-ABEE-EE85C0A8BFEFQ33362775-150C71F6-FA91-420E-9552-F190CA381BD2Q33378748-EE21E4B9-8A69-4F71-AE4A-E2E1D17CBD6BQ33384926-91C1C261-2B64-4364-A1F5-819F21D73068Q33660354-29BF5FDC-08EC-476B-B4A5-75710127E97BQ35679349-006F05B5-3A0F-487A-A58E-ED67679F68EDQ35922755-C3B39BD7-EBBD-4438-875E-C5027505B3C6Q35970460-E354BE33-3AA8-4FDF-9998-5805E67ABC2BQ36089005-94512CA8-AB9A-4AF5-9F08-1B280AE8F944Q36204792-B857731B-A5C4-46C0-8B4E-9474E4368232Q36402262-3CEB795E-51CD-405C-A005-E264E871D49DQ36927249-8A645523-EEA1-418A-A8B4-A956D8555D92Q37531844-13873000-6DF7-4DBC-A251-FCDB71F7B321Q37918075-2626E585-97F9-4D0A-8617-370AB1FC6859Q38017026-CAE5189C-CA73-4692-90E5-220C40CAB6C6Q38085587-E7AA6227-2C5C-41E8-BFCE-13B300526167Q38449565-FED7FEFB-02E8-42C7-904E-05558AC8F44AQ38462629-9655F52A-42F5-478D-BC4E-D44BB3CB6F03Q38731933-40FFD8B0-A3ED-4F5A-B7D6-A478DC2B0755Q39992679-E2B185AE-9D45-4E83-AAD8-6BE7E62774FAQ41608501-C2B845DF-7F46-41AE-A0AC-35DCF423C801Q42083023-F42CF83C-15CE-4637-9D27-BD588C0739ABQ44323272-849951F3-0B17-42E9-B624-B85402040ED1Q46963868-623399AE-E879-4D19-A732-02E405E79728Q47662892-31F64A86-E2EB-407F-87A4-40F0C862B010Q47692261-B16DDFC0-44DE-4122-B8E0-D688FC473234Q47710730-7EA5EA7A-3BF0-46E0-BF79-115B306BE2C0Q48254388-74B59C78-7531-4B72-97F8-BFA5D19EEB23Q53143504-F62A6A29-4FE3-4483-92EF-BE1BE26A2602Q53251807-BE9A173C-7DD4-41AC-892F-7F21560DD372Q53839396-DAA1C9EB-198D-4DFB-B1AC-920C7E304DF6Q64991535-CE74EB79-4BC8-43C4-BC2A-E1B523E24F13Q74528325-7C86E274-AC66-4918-B195-3824C56173E2Q77715529-A45BB8B2-EF54-4895-B97C-6E65638CF424Q80230321-D3EBE488-79D7-4FE1-8B15-6F898AE036E9Q80626247-789183FE-5421-450D-8A98-704B9A82A744Q84773122-4A4D38C6-B09D-4E4B-997D-6073ACCA03BBQ85994222-566E297D-2404-427D-BD34-229770A0AB13Q90394496-23045DE0-B31C-4562-88C0-F239D3111D3FQ90833565-B8036746-B693-45A1-9866-14BBC8CB3A10
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anna Koumarianou
@ast
Anna Koumarianou
@en
Anna Koumarianou
@es
Anna Koumarianou
@nl
Anna Koumarianou
@sl
type
label
Anna Koumarianou
@ast
Anna Koumarianou
@en
Anna Koumarianou
@es
Anna Koumarianou
@nl
Anna Koumarianou
@sl
prefLabel
Anna Koumarianou
@ast
Anna Koumarianou
@en
Anna Koumarianou
@es
Anna Koumarianou
@nl
Anna Koumarianou
@sl
P106
P21
P31
P496
0000-0002-4159-2511